BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Queensland Health
Argus Health

Generated: November 23, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,708,011

« Back to Dashboard

Summary for Patent: 5,708,011

Title: Use of levobupivacaine in a patient having depressed myocardial contractility
Abstract:This application relates to methods of using levobupivacaine substantially free of dexbupivacaine for anaesthetic treatment of pain in a patient having depressed myocardial contractility.
Inventor(s): Bardsley; Hazel Judith (Cambridge, GB), Gristwood; Robert William (Cambridge, GB)
Assignee: Chiroscience Limited (Cambridge, GB)
Application Number:08/640,930
Patent Claim Types:
see list of patent claims
Use; Device;

No matches for this query

Foreign Priority and PCT Information for Patent: 5,708,011

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9321061Oct 13, 1993
United Kingdom9408014Apr 22, 1994
PCT Information
PCT FiledOctober 13, 1994PCT Application Number:PCT/GB94/02249
PCT Publication Date:April 20, 1995PCT Publication Number: WO95/10277

International Patent Family for Patent: 5,708,011

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria150643► Subscribe
Austria154758► Subscribe
Austria210982► Subscribe
Austria243036► Subscribe
Australia5183098► Subscribe
Australia5339596► Subscribe
Australia692477► Subscribe
Australia694453► Subscribe
Australia700902► Subscribe
Australia704806► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Cantor Fitzgerald
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus